Attachment E - Estimated Order Volume by Vaccine Brand.pdf
PDF 242 KB Posted
- Attached to
- New York State Vaccine Program Supply
- Solicitation number
- 2138013
- Issued by
- New York
About this file
This document is Attachment E to an Invitation for Bids issued by the New York State Department of Health for the New York State Vaccine Program Supply contract. The attachment provides estimated annual order volumes for 2025-2026 across pediatric and adult vaccine categories serving Child Health Plus enrollees, underinsured children, and underinsured and uninsured adults. The pediatric vaccine portfolio includes 52 vaccine brands with a total estimated volume of 848,800 doses, while the adult vaccine portfolio includes 41 vaccine brands with a total estimated volume of 58,377 doses, for a combined grand total of 895,500 doses. The contract will cover all vaccines identified on the Current CDC Vaccine Price List. The IFB was issued on August 6, 2026, with a deadline for written questions on August 13, 2026 at 5:00 p.m. ET, responses to questions posted on or about August 28, 2026, and a bid submission deadline of September 10, 2026 at 5:00 p.m. ET. The anticipated contract start date is April 1, 2027.
The estimated order volumes provided in this attachment are based on annual doses shipped to providers during 2025-2026 and are subject to adjustment based on the population of uninsured, underinsured, and Child Health Plus enrollees in New York State. The Department reserves the right to order up to 25 percent above the listed volumes to maintain adequate inventory at the distribution center. The document notes that Nuvaxovid and Afluria order volumes for 2025-2026 are included for reference but were not included on the CDC price list at the time of IFB posting due to the seasonal nature of certain vaccines; however, these vaccines may be added in the future. No specific pricing terms, set-asides, or incumbent information is detailed in this attachment. There are no minority/women business enterprise, disadvantaged business enterprise, or service-disabled veteran-owned business contracting goals specified for this procurement.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Attachment B - Application Form.pdf | ||
| Attachment C - Bid Form.xlsx | XLSX spreadsheet | |
| Invitation for Bids.pdf | ||
| Attachment D - Bid Form Instructions.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Vaccine Brand Total
ABRYSVO 100
ACTHIB 13,400
ADACEL 13,760
AFLURIA* 300
BEXSERO 20,220
BEYFORTUS 13,370
BOOSTRIX 21,630
COMIRNATY (12+) 1,470
COMIRNATY (5-11y) 1,380
DAPTACEL 10,810
ENFLONSIA 640
ENGERIX B 31,240
FLUARIX 40,770
FLUCELVAX 22,210
FLULAVAL 48,660
FLUMIST 7,790
FLUZONE 54,150
GARDASIL9 51,270
HAVRIX 34,680
HIBERIX 5,950
INFANRIX 13,700
IPOL 15,980
JYNNEOS 40
KINRIX 18,570
MENQUADFI 32,070
MENVEO ONE-VIAL 20,260
MENVEO TWO-VIAL 80
M-M-R II 28,410
NUVAXOVID* 30
PEDIARIX 16,570
PEDVAXHIB 8,620
PENBRAYA 1,540
PENMENVY 1,980
PENTACEL 22,770
PNEUMOVAX 23 610
PEDIATRIC
ATTACHMENT E: Estimated Order Volume by Vaccine Brand
The volume below is based on annual doses shipped to providers 2025-2026.
New York State may order up to 25% over the volume listed to keep adequate ordering inventory at distribution center. Volume may change based on population of uninsured, underinsured and Child Health Plus enrollees in New York State.
PREVNAR 20 69,850
PRIORIX 2,630
PROQUAD 26,220
QUADRACEL 5,940
RECOMBIVAX HB 10,330
ROTARIX 15,670
ROTATEQ 31,780
SPIKEVAX (12+) 4,030
SPIKEVAX (6mo-11y) 6,630
TENIVAC 1,780
TRUMENBA 3,270
VAQTA 16,750
VARIVAX 30,980
VAXELIS 35,830
VAXNEUVANCE 12,080
Pediatric Total 848,800
Vaccine Brand Total
ABRYSVO 610
ADACEL 705
AFLURIA* 450
AREXVY 130
BEXSERO 266
BOOSTRIX 6,140
CAPVAXIVE 1,880
ENGERIX B 2,980
FLUARIX 4,970
FLUCELVAX 4,410
FLULAVAL 6,240
FLUMIST 20
FLUZONE 2,700
GARDASIL9 4,800
HAVRIX 1,630
HEPLISAV-B 3,125
IPOL 1,450
JYNNEOS 240
MENQUADFI 270
MENVEO ONE-VIAL 640
M-M-R II 3,060
ADULT
NUVAXOVID* 100
PENBRAYA 14
PENMENVY 50
PNEUMOVAX 23 72
PREVNAR 20 2,460
PRIORIX 510
RECOMBIVAXHB 20
SHINGRIX 2,800
TENIVAC 635
TRUMENBA 90
TWINRIX 690
VAQTA 210
VARIVAX 1,560
SPIKEVAX (12+) 1,930
COMIRNATY (12+) 520
Adult Total 58,377
Grand Total 895,500
*2025-26 order volume for Nuvaxovid and Afluria are included in this attachment for reference. They are not included on the CDC price list at the time of IFB posting, but they may be added in the near future. This is due to the seasonal nature of some vaccines.
File details come from the government source that posted it. Updated .